FDA Inspection 1084105 — Jiangxi Fushine Pharmaceutical Co., Ltd.
The FDA completed an inspection of Jiangxi Fushine Pharmaceutical Co., Ltd. on Jan 18, 2019 in Jing Dezhen. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 18, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jing Dezhen (China)